NeuroOne Medical Technologies Corp. (NMTC)
1.62
-0.04
(-2.41%)
USD |
NASDAQ |
Sep 04, 16:00
1.64
+0.02
(+1.23%)
After-Hours: 20:00
NeuroOne Medical Technologies Shareholders Equity (Quarterly) : 3.768M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.768M |
| March 31, 2026 | 5.077M |
| December 31, 2025 | 6.402M |
| September 30, 2025 | 7.072M |
| June 30, 2025 | 8.178M |
| March 31, 2025 | 1.126M |
| December 31, 2024 | 2.935M |
| September 30, 2024 | 0.822M |
| June 30, 2024 | 3.012M |
| March 31, 2024 | 3.854M |
| December 31, 2023 | 4.418M |
| September 30, 2023 | 6.249M |
| June 30, 2023 | 3.921M |
| March 31, 2023 | 5.533M |
| December 31, 2022 | 8.172M |
| September 30, 2022 | 9.604M |
| June 30, 2022 | 10.62M |
| March 31, 2022 | 13.12M |
| December 31, 2021 | 15.95M |
| September 30, 2021 | 6.554M |
| June 30, 2021 | 8.855M |
| March 31, 2021 | 10.86M |
| December 31, 2020 | 1.408M |
| September 30, 2020 | 2.066M |
| June 30, 2020 | -3.927M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.185M |
| December 31, 2019 | -4.612M |
| September 30, 2019 | -1.238M |
| June 30, 2019 | -0.2734M |
| March 31, 2019 | 0.4446M |
| December 31, 2018 | -4.958M |
| September 30, 2018 | -4.396M |
| June 30, 2018 | -7.288M |
| March 31, 2018 | -6.395M |
| December 31, 2017 | -5.037M |
| September 30, 2017 | -3.529M |
| June 30, 2017 | -0.1285M |
| March 31, 2017 | -0.1049M |
| December 31, 2016 | -0.2662M |
| September 30, 2016 | -0.1052M |
| June 30, 2016 | -0.0995M |
| March 31, 2016 | -0.0847M |
| December 31, 2015 | -0.0815M |
| September 30, 2015 | -0.0639M |
| June 30, 2015 | -0.0571M |
| March 31, 2015 | -0.035M |
| December 31, 2014 | -0.0354M |
| September 30, 2014 | -0.0255M |
| June 30, 2014 | -0.0194M |
| March 31, 2014 | -0.0034M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.186M |
| Total Liabilities (Quarterly) | 2.419M |
| Debt to Equity Ratio | 0.0465 |
| Current Ratio | 2.820 |
| Net Debt Paydown Yield | 0.10% |